Home › Cohorts › Fecal Butyrate and Deoxycholic Acid Concentrations Correlate With Mortality in Patients With Liver Disease.
Fecal Butyrate and Deoxycholic Acid Concentrations Correlate With Mortality in Patients With Liver Disease. PCB0C53AB7
6 studies · 1,334 curated samples · 684 distinct subject identifiers · 3 shared papers. Grouping rule: shared own-data paper.
Age categories
| unknown | 972 |
| adult | 322 |
| elderly | 40 |
Countries
| US | 1,334 |
Health conditions
| liver_disease Liver disease (cirrhosis | 972 |
| other_disease Other disease / condition | 196 |
| other_infection Other infection (HIV | 71 |
| transplant_or_immunocompromised Transplant / immunocompromised (HSCT | 48 |
| healthy_control Healthy / control | 47 |
Studies
| study | title | samples | source |
|---|---|---|---|
| PRJNA912122 | Lactulose-mediated Bifidobacteria expansion promotes a beneficial fecal metabolite profile that is associated with exclusion of antibiotic-resistant pathogens and improved outcomes in advanced liver disease | 850 | gut_all_v1 |
| PRJNA1134172 | Fecal metabolite profiling identifies critically ill patients with increased 30-day mortality risk | 196 | gut_all_v1 |
| PRJNA1184735 | Fecal butyrate and deoxycholic acid concentrations correlate with mortality in hospitalized patients with liver disease | 122 | gut_all_v1 |
| PRJNA842425 | Alterations of the Microbiome During Critical Illness with short and long term clinical outcomes | 71 | gut_all_v1 |
| PRJNA845905 | Donor Specific Antibodies and the Microbiome in Heart Transplant Patients | 48 | gut_all_v1 |
| PRJNA838648 | Healthy Human Stool Donors from Duchossois Family Institute at University of Chicago | 47 | gut_all_v1 |
Shared papers
- Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease. — PMID 37845315 · PMC11059310 · doi · studies: PRJNA838648, PRJNA912122
- Fecal Butyrate and Deoxycholic Acid Concentrations Correlate With Mortality in Patients With Liver Disease. — PMID 40574876 · PMC12197998 · doi · studies: PRJNA1134172, PRJNA1184735, PRJNA838648, PRJNA842425, PRJNA912122
- The intestinal microbiota impacts nutritional immunity and resistance to <i>Acinetobacter baumannii</i> pneumonia. — PMID 42012958 · PMC13123906 · doi · studies: PRJNA1134172, PRJNA838648, PRJNA845905